C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/10 (2006.01) A61K 31/4174 (2006.01) A61K 31/4439 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01) C07D 233/64 (2006.01) C07D 403/10 (2006.01) C07D 471/04 (2006.01)
Patent
CA 2667003
Certain novel substituted imidazoles are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes.
L'invention concerne certains nouveaux imidazoles substitués qui sont des ligands du récepteur de la bombésine humain et, en particulier, des ligands sélectifs du sous-type 3 du récepteur de la bombésine humaine (BRS-3). Lesdits imidazoles substitués sont utiles dans le traitement, le contrôle et la prévention de maladies et de troubles réagissant à la modulation du BRS-3, comme l'obésité et le diabète.
Dobbelaar Peter H.
Franklin Christopher L.
Goodman Allan
Guo Cheng
Guzzo Peter R.
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Substituted imidazoles as bombesin receptor subtype-3... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted imidazoles as bombesin receptor subtype-3..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted imidazoles as bombesin receptor subtype-3... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1522590